8
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T7708 | DL-Buthionine-(S,R)-sulfoximine | Butionine sulfoximine,NSC 381100,D,L-Buthionine-(S,R)-sulfoximine | Others , Ferroptosis |
DL-Buthionine-(S,R)-sulfoximine (Butionine sulfoximine) is an inhibitor of γ-glutamylcysteine synthetase for the treatment of solid tumors. | |||
T5371 | L-BUTHIONINE-(S,R)-SULFOXIMINE | L-Butionine sulfoximine | Others , Ferroptosis |
L-Buthionine-(S,R)-sulfoximine is a cell-permeable and irreversible inhibitor of γ-glutamylcysteine synthetase (Ki <100 μM) that induces oxidative stress in cells by depleting GSH. | |||
T41299 | L-Methionine-DL-sulfoximine | MSX,MSO | Others |
L-Methionine-DL-sulfoximine (MSO) inhibits glutamine synthetase and metabolically and morphologically primarily affects astroglia. L-Methionine-DL-sulfoximine can be used in convulsant studies. | |||
T70016 | Methionine sulfoximine | ||
Methionine sulfoximine (MSO) is an irreversible glutamine synthetase inhibitor. It is the sulfoximine derivative of methionine with convulsant effects. | |||
T60406 | DL-Buthionine-(S,R)-sulfoximine hydrochloride | ||
DL-Buthionine-(S,R)-sulfoximine hydrochloride (Buthionine sulfoximine hydrochloride) is a potent and specific glutamylcysteine synthetase biosynthesis inhibitor. | |||
T60407 | L-Buthionine-(S,R)-sulfoximine hydrochloride | ||
L-Buthionine-(S,R)-sulfoximine hydrochloride is a potent, cell-permeable, fast-acting and irreversible inhibitor of G-glutamylcysteine synthetase (γ-GCS) and depletes cellular glutathione levels. L-Buthionine-(S,R)-sulfo... | |||
T19940 | Sulfoxaflor | GF 2372,GF 2032,XDE 208 | AChR |
Sulfoxaflor (GF 2032), an agonist of nAChR1 and nAChR2 subtypes, is a systemic insecticide that acts on the central nervous system of insects. Sulfoxaflor is used for the control of sap-feeding insects such as Nilaparvat... | |||
T12795 | (S)-Ceralasertib | (S)-AZD6738 | Others |
(S)-Ceralasertib is a potent and selective inhibitor of sulfoximine morpholinopyrimidine ATR with excellent preclinical physicochemical and pharmacokinetic (PK) characteristics. . |